Pulmonary Hypertension News

Tenax Therapeutics has raised about $100 million to accelerate the clinical development of oral levosimendan for treating PH-HFpEF.

$100M raised to speed up development of PH therapy oral levosimendan

Columnist Anna Jeter never enters the hospital without her headphones. Part of the power of music is its familiar, healing nature.

Channeling the power of music as my anchor in life

In hip fracture patients, PH was tied to higher post-surgical mortality, major in-hospital complications, and hospital re-admissions.

Study: Pulmonary hypertension worsens outcomes after hip fracture...

Columnist Jen Cueva interviews her colleague and friend Jenn Powell about their special friendship and life with chronic illness.

A special friendship forged by the unique world of chronic illness

For PAH patients both with and without co-occurring heart problems, combination therapy with macitentan and tadalafil is similarly effective.

Macitentan-tadalafil combination therapy effective in PAH: Analysis

Children of cigarette-smoking parents have a higher risk of developing pulmonary arterial hypertension within a year of birth, a study found.

Parental cigarette smoking raises their babies' PAH risk : Study

Symptom tracking takes some practice at first, but it pays off over time and can make PH care more efficient, columnist Jen Cueva says.

Why symptom tracking is important for managing PH

A study into a global survey of clinicians treating CTEPH found management differences, highlighting need for better care standards.

Ways of treating CTEPH can vary widely across globe, study finds

Tectonic Therapeutic plans to soon launch a global Phase 2 study of TX45, an injection therapy, in a broad range of PH-HFpEF patients.

FDA paves way for Phase 2 clinical trial of TX45 for PH-HFpEF

The U.S. Food and Drug Administration has given orphan drug designation to ZM001, an investigational antibody for PAH.

ZM001 gets FDA orphan drug designation for PAH

Healthcare costs for mid- and high-risk PAH patients dropped after diagnosis, though higher-risk patients had worse life quality, per a study.

Healthcare costs decline after PAH diagnosis, study says

Columnist Jen Cueva shares insight she's gleaned over the years about how to respond to a pulmonary hypertension diagnosis.

So you’ve just received a pulmonary hypertension diagnosis. What now?

Yuvanci, a combination tablet containing macitentan and tadalafil, is recommended by CHMP for approval as a PAH treatment in the EU.

EU approval of combo tablet Yuvanci for PAH favored by CHMP

Measuring blood vessel function in the arm in a noninvasive way can help predict the severity of PH when combined with certain heart tests, a study says.

Testing blood vessel function in arm may help predict PH: Study

Multiple medications are crucial to PH treatment strategies, but they have a cost in terms of side effects, says columnist Anna Jeter.

The harsh reality of medication side effects in PH and transplant

Columnist Jen Cueva shares strategies that help her combat impostor syndrome when her rare disease triggers feelings of inadequacy.

pulmonaryhypertensionnews.com

A study found 5-HIAA and IGF-1 levels differed in young children with PH and congenital heart disease, and could be PH diagnostic markers.

Molecules in blood, urine may help detect PH in children with CHD

Healthcare costs are over eight times higher for PAH versus other patients, helping create a greater economic burden, per a real-world study.

Economic burden in PAH mainly due to treatment, hospital costs

Sildenafil may be used to treat neonatal pulmonary hypertension at high altitudes, where less oxygen is available, researchers say.

Sildenafil may help treat neonatal PH at high altitudes: Review

Columnist Jen Cueva says that she and her husband, Manny, make a great team, which is crucial when living with a rare disease.

Marriage looks a little different when living with a rare disease

High blood levels of resistin, a hormone produced by fat cells, may help to recognize a higher clinical worsening risk in PAH, a study shows.

Resistin hormone levels help predict PAH disease severity...

PH can make going to a concert or other outing more complicated, columnist Mike Naple says. Concert venue bag policy is one consideration.

How I navigate concert venue bag policy and other considerations

The FDA has tentatively approved Alembic Pharmaceuticals' generic formulation of injectable selexipag as a PAH treatment.

FDA tentatively approves generic selexipag as PAH treatment

A natural substance from a houseplant shows promise as a potential treatment to prevent and reverse pulmonary hypertension (PH), per a study.

Plant-derived substance shows promise as PH treatment: Study

The patent for brilaroxazine covers those with PAH and those who develop PH associated with COPD or sickle cell disease.

Using Reviva's brilaroxazine in PH covered by new European patent

Columnist Jen Cueva likes to take charge of her life, but the unpredictability of PH forces her to practice letting go of control.

Letting go of control is challenging in life with a rare disease

Anumana's artificial intelligence algorithm shows promise as a tool for the early detection of pulmonary hypertension, per a study.

AI algorithm shows promise for early detection of PH: Study

Pulnovo Medical reports that 2 pulmonary hypertension patients with left heart disease in Portugal underwent procedure in new global study.

Trial of PADN device for PH with left heart disease opens in Europe

Because columnist Mike Naples has PH, he must pay attention to hot dog sodium content this summer, which for him is a tough ask.

Hot dog sodium content puts limits on my favorite summer food

A European Medicines Agency branch recommended Winrevair to improve exercise capacity in PAH patients in WHO functional class 2 or 3.

Winrevair approval favored to aid exercise in adults with PAH in EU